Dividends CalendarEarnings Calendar
CLLS

CLLS | Cellectis SA

17.83 -0.56 (-3.24%) 
Healthcare sector
Cellectis SA
Category: Company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   France

Trade prices

  • Volume: 79.9K
  • Market Cap: 713.85M
  • Prev closed: 18.65
  • Open: 18.85
  • High: 19.27
  • Low: 18.66
  • 52 week low: 7.32
  • 52 week high: 21.97
  • Dividends:No Dividends

Next ER: August 5, 2020  After Market Closes



Top Stories (CLLS)

    About the Company

    Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris and New York City.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 5, 2020-0.68 / -0.744.62M / 4.58MBeat!
    May 6, 20200.47 / -0.6451.91M / 16.23MBeat!
    March 16, 2020- / -0.74- / 4.97M
    March 4, 2020-0.88 / -0.746.34M / 4.97MBeat!
    November 19, 2019- / -0.81- / 3.52M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 18, 2020 17.96 17.80
    18.00
    17.55
    		 112.06K 4.30%
    Aug 17, 2020 17.22 17.29
    17.70
    17.17
    		 174.38K 0.58%
    Aug 14, 2020 17.12 16.99
    17.18
    16.74
    		 54.63K 0.77%
    Aug 13, 2020 16.99 17.04
    17.27
    16.79
    		 92.06K 1.13%
    Aug 12, 2020 16.80 17.33
    17.33
    16.64
    		 104.65K -2.44%
    Aug 11, 2020 17.22 18.00
    18.09
    17.18
    		 138.25K -1.6%
    Aug 10, 2020 17.50 17.50
    17.75
    17.02
    		 70.25K 0.06%
    Aug 7, 2020 17.49 17.20
    17.75
    16.98
    		 86.83K 3.43%
    Aug 6, 2020 16.91 17.93
    17.95
    16.84
    		 135.65K -4.89%
    Aug 5, 2020 17.78 17.14
    17.78
    17.07
    		 110.79K 3.01%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:1999
    • Employees:122

    News

    News for (CLLS)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  André Choulika, PhD

    Talk about Cellectis SA below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Aug 5, 2020 (Same day)

    znga gddy sq hmc clls w wen syna wdc dnow disca cf 


    Jump to (Finance sites)

    Google     
             

    Research 


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    WikipediaTwitterLinkedInYoutube

    Peers / Similar stocks 

    xlv regn 

    Other stocks 

    baba bac wfc jpm jwn chl bks kr kss len keys mrvl 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet